LGND ligand.com Operatsion rentabellik

Ommaviy kompaniya Ligand Pharmaceuticals Incorporated (LGND) logotipi

Ligand Pharmaceuticals (LGND) o'zining Captisol platformasini litsenziyalash va royalti to'lovlari orqali daromad keltiradi hamda ishlab chiqarish hajmlarini past darajada ushlab turish orqali ekologik muvofiqlikni ta'minlaydi. Operatsion marjaning tahlili biznes modelining barqarorligini ko'rsatadi, bunda qiymat 14.40 darajasida saqlanmoqda. Daromadlilik kompaniyaning ilmiy ishlanmalaridan foydalanganlik uchun bosqichma-bosqich to'lovlarni amalga oshiruvchi biofarmatsevtika gigantlari bilan hamkorlikka asoslangan.

LGND: Ligand Pharmaceuticals Incorporated Operatsion foyda bo'yicha sotuv rentabelligi 04.07.2022 - 20.11.2026

Ligand Pharmaceuticals (LGND) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning fundamental baholanishi:Ligand Pharmaceuticals Incorporated, LGND
Ligand Corp asosiy tovari

Ligand Pharmaceuticals (LGND) moliyaviy barqarorlik bevosita hamkor dori vositalarining tijorat muvaffaqiyatiga va patent himoyasiga bog'liq bo'lgan yuqori xavfli sektorda faoliyat yuritadi. Operatsion marja taqsimotini tahlil qilish orqali investor asosiy operatsiyalardan tushgan foydaning umumiy daromadga nisbatan ulushini baholaydi, bu esa xarajatlarni boshqarish samaradorligini hamda soliqlar va foiz majburiyatlarigacha bo'lgan royalti to'lovlari kamayishi xavflarini aniqlashga yordam beradi.

Asosiy raqobatchilar

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion rentabellik Amneal AMRX|Operatsion foyda bo'yicha marjinallik Perrigo Company PLC|Alvotech Biopharmaceuticals - Operatsion marja|Operatsion faoliyat rentabelligi Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Operatsion rentabellik|anipharmaceuticals.com - Operatsion foyda normasi|Sotuvning operatsion marjasi MNKD|AMPH: Operatsion foyda normasi|Operatsion rentabellik pacira.com (PCRX)|Operatsion marja ARS Pharma (SPRY)|Theravance Biopharma - Sotuvning operatsion marjasi|Operatsion foyda koeffitsiyenti AQST (Aquestive Therapeutics)|SCPH: Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Tectonic Therapeutic|TNXP: Operatsion marja|SXT China (SXTC) - Operatsion marja|Operatsion rentabellik eupraxiapharma.com|BioHarvest Sciences (BHST) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Invizyne (EXOZ)|ORMP - Sotuvning operatsion rentabelligi|Operatsion marja ENTX (Entera Bio)|Operatsion foyda bo'yicha marjinallik MindWalk Therapeutics|ABVC: Sotuvning operatsion marjasi|CPIX - Operatsion marja|QNTM (Quantum BioPharma) - Sotuvning operatsion marjasi|Operatsion foyda marjasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operatsion marja|Operatsion marja ranitherapeutics.com|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.